Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

Bayer signs licensing agreement with Nagasaki University to use tracers in PET in AD

Sep. 15, 2008

Epix to regain worldwide commercialization rights to Vasovist

Sep. 8, 2008

Development of cannabinoid CB1 ligands for brain imaging described

Sep. 3, 2008

Eisai offers Q1 overview

Sep. 1, 2008

GlaxoSmithKline reports on efforts to identify GlyT-1 inhibitors for schizophrenia

Aug. 28, 2008

FDA fast tracks ferumoxytol for vascular-enhanced magnetic resonance imaging

Aug. 22, 2008

FDA approves Gen-Probe's supplemental regulatory application for Procleix Ultrio in HBV

Aug. 18, 2008

VAP-1 ligands for diagnosing inflammatory disorders claimed in recent patent

Aug. 18, 2008

Novel agents for diagnosis of AD discussed in Nihon Medi-Physics patent

Aug. 11, 2008

PET probe developed for imaging of immune disorders

Aug. 7, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.